Growth Ahead In Market For Vein-Viewing Technologies
Executive Summary
Patient safety concerns and limited payments for hospital-acquired conditions (HACs) are fueling double-digit growth in the multibillion-dollar market for point-of-care vascular imaging devices as hospitals increasingly look to these vein-viewing technologies to improve patient satisfaction and minimize complications associated with venous access procedures.
You may also be interested in...
New Products In Brief
Recent product approvals and launches
Huma Secures EU MDR Approval For Medtech Software That Can Be Used In Any Disease
Huma Therapeutics has secured the first ever EU regulatory approval for a “disease agnostic” class IIb medtech software platform. CEO Dan Vahdat tells Medtech Insight how the product can be configured to monitor patients with any condition.
Moderna CEO Hearing Highlights Dissatisfaction With Patient Assistance Programs
There was bipartisan agreement that Moderna need to ensure that its patient assistance program will be easily accessible for under- and uninsured patients once the US switches to a commercial market for COVID vaccines – a sign of broader frustration with industry copay support initiatives.